Expasy logo

UniProtKB/Swiss-Prot variant pages

UniProtKB/Swiss-Prot P00966: Variant p.Ala192Val

Argininosuccinate synthase
Gene: ASS1
Feedback?
Variant information Variant position: help 192 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Type of variant: help LP/P [Disclaimer] The variants are classified into three categories: LP/P, LB/B and US.
  • LP/P: likely pathogenic or pathogenic.
  • LB/B: likely benign or benign.
  • US: uncertain significance
Residue change: help From Alanine (A) to Valine (V) at position 192 (A192V, p.Ala192Val). Indicates the amino acid change of the variant. The one-letter and three-letter codes for amino acids used in UniProtKB/Swiss-Prot are those adopted by the commission on Biochemical Nomenclature of the IUPAC-IUB.
Physico-chemical properties: help Change from small size and hydrophobic (A) to medium size and hydrophobic (V) The physico-chemical property of the reference and variant residues and the change implicated.
BLOSUM score: help 0 The score within a Blosum matrix for the corresponding wild-type to variant amino acid change. The log-odds score measures the logarithm for the ratio of the likelihood of two amino acids appearing by chance. The Blosum62 substitution matrix is used. This substitution matrix contains scores for all possible exchanges of one amino acid with another:
  • Lowest score: -4 (low probability of substitution).
  • Highest score: 11 (high probability of substitution).
More information can be found on the following page
Variant description: help In CTLN1; decreased protein abundance. Any additional useful information about the variant.


Sequence information Variant position: help 192 The position of the amino-acid change on the UniProtKB canonical protein sequence.
Protein sequence length: help 412 The length of the canonical sequence.
Location on the sequence: help PVTPKNPWSMDENLMHISYE A GILENPKNQAPPGLYTKTQD The residue change on the sequence. Unless the variant is located at the beginning or at the end of the protein sequence, both residues upstream (20) and downstream (20) of the variant will be shown.
Residue conservation: help The multiple alignment of the region surrounding the variant against various orthologous sequences. 
Human                         PVTPKNPWSMDENLMHISYEAGILENPKNQAPPGLYTKTQD

Mouse                         PVTPKSPWSMDENLMHISYEAGILENPKNQAPPGLYTKTQD

Rat                           PVTPKSPWSMDENLMHISYEAGILENPKNQAPPGLYTKTQD

Bovine                        PVTPKNPWSMDENLMHISYEAGILENPKNQAPPGLYTKTQD

Chicken                       PVTPKAPWSMDENLMHISYEAGILENPKNRAPLDLYTKTCN

Xenopus laevis                PVTPKSPWSMDENLMHISYEGGILENPKNHAPPGLYLKTKD

Xenopus tropicalis            PVTPKDPWSMDENIMHISYEGGILENPKNHAPPGLYLKTKN

Zebrafish                     PVTPKAPWSMDANLMHISYESGILENPKNHAPSDLYQMTKN

Drosophila                    SAKPATPWSTDANILHISYESGILEDPNTVAPENLYEMTVD

Baker's yeast                 AQTKAKPWSTDENQAHISYEAGILEDPDTTPPKDMWKLIVD

Fission yeast                 TQTTKKPWSMDENIVHCSYEAGILEDPSMTPPKDMWKLTVD
Sequence annotation in neighborhood: help The regions or sites of interest surrounding the variant. In general the features listed are posttranslational modifications, binding sites, enzyme active sites, local secondary structure or other characteristics reported in the cited references. The "Sequence annotation in neighborhood" lines have a fixed format:
  • Type: the type of sequence feature.
  • Positions: endpoints of the sequence feature.
  • Description: contains additional information about the feature.
TypePositionsDescription
Chain 1 – 412 Argininosuccinate synthase
Binding site 180 – 180
Binding site 189 – 189
Modified residue 176 – 176 N6-acetyllysine; by CLOCK
Modified residue 180 – 180 Phosphoserine
Mutagenesis 176 – 176 K -> QR. Significant loss of acetylation but no decrease in enzyme activity; when associated with Q-165 or R-165.



Literature citations
Characterization of human wild-type and mutant argininosuccinate synthetase proteins expressed in bacterial cells.
Shaheen N.; Kobayashi K.; Terazono H.; Fukushige T.; Horiuchi M.; Saheki T.;
Enzyme Protein 48:251-264(1994)
Cited for: CHARACTERIZATION OF VARIANTS CLNT1 VAL-192; ARG-280; CYS-272 AND TRP-304; FUNCTION; CATALYTIC ACTIVITY; PATHWAY; Mutations in argininosuccinate synthetase mRNA of Japanese patients, causing classical citrullinemia.
Kobayashi K.; Shaheen N.; Terazono H.; Saheki T.;
Am. J. Hum. Genet. 55:1103-1112(1994)
Cited for: VARIANTS CTLN1 THR-118; VAL-192; CYS-272; ARG-280; TRP-304 AND LEU-363;
Disclaimer: Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. They are not in any way intended to be used as a substitute for professional medical advice, diagnostic, treatment or care.